Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8313655
Reference Type
Journal Article
Title
Paraplegia following intrathecal chemotherapy
Author(s)
Saiki, JH; Thompson, S; Smith, F; Atkinson, R
Year
1972
Is Peer Reviewed?
Yes
Journal
Cancer
ISSN:
0008-543X
EISSN:
1097-0142
Volume
29
Issue
2
Page Numbers
370-374
Language
English
DOI
10.1002/1097-0142(197202)29:2<370::AID-CNCR2820290217>3.0.CO;2-Z
Abstract
A case report and review of the literature of paraplegia following intrathecal chemotherapy with methotrexate and cytosine arabinoside is presented. Autopsy identified damage to the spinal nerve roots within the subarachnoid space, which accounted for the neurologic deficit. The only substances common to both chemotherapeutic agents were their preservatives, methylhydroxybenzoate and benzyl alcohol, which were used, in the diluent. Prolonged exposure to these preservatives is known to cause severe neurotoxicity. Though the specific agent responsible for paraplegia following intrathecal chemotherapy is unknown, there is evidence to suggest that the preservatives rather than the therapeutic agents themselves are responsible. Copyright © 1972 American Cancer Society
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity